1174068-40-6

Basic information

• Product Name: 4-[1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-piperidin-2-yl]-butyric acid
• Synonyms: 4-[1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-piperidin-2-yl]-butyric acid
• CAS NO: 1174068-40-6
• Molecular Weight: 369.482
• Mol File: 1174068-40-6.mol

Chemical Properties

• CAS DataBase Reference: 4-[1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-piperidin-2-yl]-butyric acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-piperidin-2-yl]-butyric acid(1174068-40-6)
• EPA Substance Registry System: 4-[1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-piperidin-2-yl]-butyric acid(1174068-40-6)

Safety Data

• Hazardous Substances Data: 1174068-40-6(Hazardous Substances Data)

Upstream product

• 55661-08-0 4-methoxy-2,6-dimethylbenzenesulfonyl chloride 
• 1187963-87-6 4-((1-tert-butoxycarbonyl)piperidin-2-yl)butanoic acid 
• 1187963-89-8 4-(piperidin-2-yl)butanoic acid methyl ester hydrochloride 
• 1187963-88-7 tert-butyl-2-(4-methoxy-4-oxobutyl)piperidine-1-carboxylate 
• 170491-61-9 2-(2-oxoethyl)-1-piperidinecarboxylic acid tert-butyl ester 
• 118811-03-3 tert-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate 
• 63987-69-9 4-[2]piperidyl-butyric acid ; hydrochloride 
• 874-63-5 3,5-dimethylmethoxybenzene 
• 946484-69-1 C₁₆H₂₇NO₄ 
• 946484-70-4 2-[3-(ethoxycarbonyl)propyl]piperidine-1-carboxylic acid tert-butyl ester 
• 1484-84-0 2(RS)-(2-hydroxyethyl)piperidine 
• 1174068-39-3 C₂₀H₃₁NO₅S 

Downstream Products

• 1190970-02-5 1-(4-ethyl-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-4-(1-(4-methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)butan-1-one 

Relevant articles and documents

Substituted Spiroamine Compounds

Substituted spiroamine compounds corresponding to the formula (I) In which m, n, o, p, Q, r, s, t, R1, R2, R3, R4a, R4b, R5a, R5b, R6a, R6b, R7, R8, R9, R10 and R11 have defined meanings; a process for the preparation of such compounds, pharmaceutical compositions containing such compounds and the use of substituted spiroamines for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin 1 receptor.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to the formula I: processes for the preparation thereof, pharmaceutical composition containing these compounds and the use of substituted sulfonamide compounds for the preparation of pharmaceutical compositions.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to formula I: a process for their preparation, pharmaceutical compositions comprising such compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment of pain or other disorders or diseases that are mediated at least in part by B1R receptors.

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives of the general formula (I'); processes for their preparation, medicaments containing these compounds, and the use of substituted sulfonamide derivatives for the preparation of medicaments

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.